Satoru Sasagawa

Satoru Sasagawa

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2005 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
SSSatoru Sasagawa
Satoru Sasagawa
YOYu-Ichi Ozaki
Yu-Ichi Ozaki
KFKazuhiro Fujita
Kazuhiro Fujita
SKShinya Kuroda
Shinya Kuroda

1 September 2006 in Genes & Development
Verified
Journal Article
Closed access
PDF file
STShugaku Takeda
Shugaku Takeda
DCDavid Y. Chen
David Y. Chen
TWTodd D. Westergard
Todd D. Westergard
JFJill K. Fisher
Jill K. Fisher
JRJeffrey A. Rubens
Jeffrey A. Rubens
JHJames J.-D. Hsieh
James J.-D. Hsieh
Taspase1 was identified as the threonine endopeptidase that cleaves mixed-lineage leukemia (MLL) for proper Hox gene expression in vitro. To investigate its functions in vivo, we generated Taspase1−/− mice. Taspase1 deficiency results in noncleavage (nc) of MLL and MLL2 and homeotic transformations. Remarkably, our in vivo studies uncover an unexpected role of Taspase1 in the cell cycle. Taspase1−/− animals are smaller in size. Taspase1−/− mouse embryonic fibroblasts (MEFs) exhibit impaired proliferation, and acute deletion of Taspase1 leads to a marked reduction of thymocytes. Taspase1 deficiency incurs down-regulation of Cyclin Es, As, and Bs and up-regulation of p16Ink4a. We show that MLL and MLL2 directly target E2Fs for Cyclin expression. The uncleaved precursor MLL displays a reduced histone H3 methyl transferase activity in vitro. Accordingly, chromatin immunoprecipitation assays demonstrate a markedly decreased histone H3 K4 trimethylation at Cyclin E1 and E2 genes in Taspase1−/− cells. Furthermore, MLLnc/nc;2nc/nc MEFs are also impaired in proliferation. Our data are consistent with a model in which precursor MLLs, activated by Taspase1, target to Cyclins through E2Fs to methylate histone H3 at K4, leading to activation. Lastly, Taspase1−/− cells are resistant to oncogenic transformation, and Taspase1 is overexpressed in many cancer cell lines. Thus, Taspase1 may serve as a target for cancer therapeutics.

1 February 2011 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
KHKunihiko Hiramatsu
Kunihiko Hiramatsu
SSSatoru Sasagawa
Satoru Sasagawa
HOHidetatsu Outani
Hidetatsu Outani
KNKanako Nakagawa
Kanako Nakagawa
HYHideki Yoshikawa
Hideki Yoshikawa
NTNoriyuki Tsumaki
Noriyuki Tsumaki
Repair of cartilage injury with hyaline cartilage continues to be a challenging clinical problem. Because of the limited number of chondrocytes in vivo, coupled with in vitro de-differentiation of chondrocytes into fibrochondrocytes, which secrete type I collagen and have an altered matrix architecture and mechanical function, there is a need for a novel cell source that produces hyaline cartilage. The generation of induced pluripotent stem (iPS) cells has provided a tool for reprogramming dermal fibroblasts to an undifferentiated state by ectopic expression of reprogramming factors. Here, we show that retroviral expression of two reprogramming factors (c-Myc and Klf4) and one chondrogenic factor (SOX9) induces polygonal chondrogenic cells directly from adult dermal fibroblast cultures. Induced cells expressed marker genes for chondrocytes but not fibroblasts, i.e., the promoters of type I collagen genes were extensively methylated. Although some induced cell lines formed tumors when subcutaneously injected into nude mice, other induced cell lines generated stable homogenous hyaline cartilage–like tissue. Further, the doxycycline-inducible induction system demonstrated that induced cells are able to respond to chondrogenic medium by expressing endogenous Sox9 and maintain chondrogenic potential after substantial reduction of transgene expression. Thus, this approach could lead to the preparation of hyaline cartilage directly from skin, without generating iPS cells.

27 January 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
HTHo-Chou Tu
Ho-Chou Tu
DRDecheng Ren
Decheng Ren
GWGary X. Wang
Gary X. Wang
DCDavid Y. Chen
David Y. Chen
TWTodd D. Westergard
Todd D. Westergard
ECEmily H.-Y. Cheng
Emily H.-Y. Cheng
Three forms of cell death have been described: apoptosis, autophagic cell death, and necrosis. Although genetic and biochemical studies have formulated a detailed blueprint concerning the apoptotic network, necrosis is generally perceived as a passive cellular demise resulted from unmanageable physical damages. Here, we conclude an active de novo genetic program underlying DNA damage-induced necrosis, thus assigning necrotic cell death as a form of “programmed cell death.” Cells deficient of the essential mitochondrial apoptotic effectors, BAX and BAK, ultimately succumbed to DNA damage, exhibiting signature necrotic characteristics. Importantly, this genotoxic stress-triggered necrosis was abrogated when either transcription or translation was inhibited. We pinpointed the p53-cathepsin axis as the quintessential framework underlying necrotic cell death. p53 induces cathepsin Q that cooperates with reactive oxygen species (ROS) to execute necrosis. Moreover, we presented the in vivo evidence of p53-activated necrosis in tumor allografts. Current study lays the foundation for future experimental and therapeutic discoveries aimed at “programmed necrotic death.”

8 May 2002 in Genesis
Verified
Journal Article
Closed access
PDF file
SSSatoru Sasagawa
Satoru Sasagawa
TTTakashi Takabatake
Takashi Takabatake
YTYuka Takabatake
Yuka Takabatake
TMTatsuo Muramatsu
Tatsuo Muramatsu
KTKazuhito Takeshima
Kazuhito Takeshima

15 March 2012 in Development
Verified
Journal Article
Open access
PDF file
SSSatoru Sasagawa
Satoru Sasagawa
HTHiroshi Takemori
Hiroshi Takemori
TUTatsuya Uebi
Tatsuya Uebi
DIDaisuke Ikegami
Daisuke Ikegami
KHKunihiko Hiramatsu
Kunihiko Hiramatsu
NTNoriyuki Tsumaki
Noriyuki Tsumaki
Chondrocyte hypertrophy is crucial for endochondral ossification, but the mechanism underlying this process is not fully understood. We report that salt-inducible kinase 3 (SIK3) deficiency causes severe inhibition of chondrocyte hypertrophy in mice. SIK3-deficient mice showed dwarfism as they aged, whereas body size was unaffected during embryogenesis. Anatomical and histological analyses revealed marked expansion of the growth plate and articular cartilage regions in the limbs, accumulation of chondrocytes in the sternum, ribs and spine, and impaired skull bone formation in SIK3-deficient mice. The primary phenotype in the skeletal tissue of SIK3-deficient mice was in the humerus at E14.5, where chondrocyte hypertrophy was markedly delayed. Chondrocyte hypertrophy was severely blocked until E18.5, and the proliferative chondrocytes occupied the inside of the humerus. Consistent with impaired chondrocyte hypertrophy in SIK3-deficient mice, native SIK3 expression was detected in the cytoplasm of prehypertrophic and hypertrophic chondrocytes in developing bones in embryos and in the growth plates in postnatal mice. HDAC4, a crucial repressor of chondrocyte hypertrophy, remained in the nuclei in SIK3-deficient chondrocytes, but was localized in the cytoplasm in wild-type hypertrophic chondrocytes. Molecular and cellular analyses demonstrated that SIK3 was required for anchoring HDAC4 in the cytoplasm, thereby releasing MEF2C, a crucial facilitator of chondrocyte hypertrophy, from suppression by HDAC4 in nuclei. Chondrocyte-specific overexpression of SIK3 induced closure of growth plates in adulthood, and the SIK3-deficient cartilage phenotype was rescued by transgenic SIK3 expression in the humerus. These results demonstrate an essential role for SIK3 in facilitating chondrocyte hypertrophy during skeletogenesis and growth plate maintenance.